Cosmos Historical Financial Ratios
| COSM Stock | USD 0.50 0.0005 0.10% |
Cosmos Health is presently reporting on over 122 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 3.44, PTB Ratio of 0.57 or Days Sales Outstanding of 82.94 will help investors to properly organize and evaluate Cosmos Health financial condition quickly.
Cosmos |
About Cosmos Financial Ratios Analysis
Cosmos HealthFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Cosmos Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Cosmos financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Cosmos Health history.
Cosmos Health Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Cosmos Health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Cosmos Health sales, a figure that is much harder to manipulate than other Cosmos Health multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Cosmos Health dividend as a percentage of Cosmos Health stock price. Cosmos Health dividend yield is a measure of Cosmos Health stock productivity, which can be interpreted as interest rate earned on an Cosmos Health investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from Cosmos Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Cosmos Health current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.At this time, Cosmos Health's Payables Turnover is very stable compared to the past year. As of the 25th of March 2025, Capex To Revenue is likely to grow to 0.16, while Days Sales Outstanding is likely to drop 82.94.
| 2022 | 2024 | 2025 (projected) | Dividend Yield | 3.64 | 3.28 | 3.44 | Price To Sales Ratio | 0.17 | 0.28 | 0.27 |
Cosmos Health fundamentals Correlations
Click cells to compare fundamentals
Cosmos Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cosmos Health fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 1.22 | 0.98 | 0.17 | 0.32 | 0.28 | 0.27 | |
| Ptb Ratio | (16.26) | 12.64 | 0.22 | 0.47 | 0.54 | 0.57 | |
| Days Sales Outstanding | 177.27 | 195.59 | 165.02 | 135.12 | 121.61 | 82.94 | |
| Book Value Per Share | (7.84) | 6.67 | 20.57 | 3.01 | 2.71 | 2.85 | |
| Free Cash Flow Yield | (0.17) | (0.14) | (1.73) | (1.47) | (1.32) | (1.39) | |
| Operating Cash Flow Per Share | (21.67) | (10.8) | (7.71) | (1.31) | (1.5) | (1.58) | |
| Capex To Depreciation | 0.3 | 1.98 | 2.03 | 14.92 | 13.43 | 14.1 | |
| Pb Ratio | (16.26) | 12.64 | 0.22 | 0.47 | 0.54 | 0.57 | |
| Ev To Sales | 11.5K | 1.79 | 1.46 | 0.001347 | 0.48 | 0.41 | |
| Free Cash Flow Per Share | (21.89) | (12.16) | (7.91) | (2.07) | (2.38) | (2.5) | |
| Inventory Turnover | 14.38 | 15.22 | 12.86 | 10.24 | 9.21 | 8.78 | |
| Net Income Per Share | 1.55 | (12.12) | (7.17) | (1.55) | (1.39) | (1.46) | |
| Days Of Inventory On Hand | 25.38 | 23.98 | 28.38 | 35.65 | 41.0 | 48.22 | |
| Payables Turnover | 3.95 | 3.76 | 4.38 | 4.12 | 3.7 | 3.86 | |
| Sales General And Administrative To Revenue | 0.0755 | 0.21 | 0.25 | 0.46 | 0.52 | 0.31 | |
| Capex To Revenue | 0.002125 | 0.0158 | 0.007609 | 0.17 | 0.15 | 0.16 | |
| Cash Per Share | 1.6 | 0.45 | 10.77 | 0.32 | 0.29 | 0.28 | |
| Pocfratio | (5.88) | (7.8) | (0.59) | (1.08) | (1.24) | (1.3) | |
| Interest Coverage | 0.97 | (1.27) | (1.88) | (25.2) | (22.68) | (23.81) | |
| Capex To Operating Cash Flow | (0.0102) | (0.13) | (0.0258) | (0.59) | (0.67) | (0.64) | |
| Pfcf Ratio | (5.82) | (6.93) | (0.58) | (0.68) | (0.78) | (0.82) | |
| Days Payables Outstanding | 92.32 | 96.95 | 83.33 | 88.68 | 101.99 | 198.85 | |
| Income Quality | 1.45 | (14.01) | 0.89 | 0.84 | 0.97 | 1.02 | |
| Roe | (0.2) | (1.82) | (0.35) | (0.51) | (0.59) | (0.56) | |
| Ev To Operating Cash Flow | (8.62) | (11.58) | (0.00456) | (1.63) | (1.87) | (1.97) | |
| Pe Ratio | 82.45 | (6.95) | (0.64) | (0.91) | (1.05) | (1.1) | |
| Return On Tangible Assets | 0.0188 | (0.16) | (0.21) | (0.32) | (0.29) | (0.3) | |
| Ev To Free Cash Flow | (83.5K) | (8.53) | (10.29) | (0.004445) | (1.18) | (1.24) | |
| Earnings Yield | 0.0121 | (0.14) | (1.57) | (1.1) | (0.99) | (1.04) | |
| Intangibles To Total Assets | 0.005257 | 0.009977 | 0.0104 | 0.12 | 0.1 | 0.11 | |
| Net Debt To E B I T D A | 9.87 | (7.03) | 0.98 | (0.5) | (0.58) | (0.61) | |
| Current Ratio | 1.17 | 1.37 | 2.58 | 1.51 | 1.35 | 0.96 | |
| Tangible Book Value Per Share | (8.27) | 5.92 | 20.2 | 2.37 | 2.13 | 2.24 | |
| Receivables Turnover | 2.06 | 1.87 | 2.21 | 2.7 | 3.11 | 2.95 | |
| Shareholders Equity Per Share | (7.84) | 6.67 | 20.57 | 3.01 | 2.71 | 2.85 | |
| Debt To Equity | (7.7) | 6.19 | 0.3 | 0.34 | 0.31 | 0.33 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.45) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.